Stocks and Investing Stocks and Investing
Fri, June 28, 2024
Thu, June 27, 2024

Steve Chesney Initiated (VRTX) at Strong Buy and Held Target at $545 on, Jun 27th, 2024


Published on 2024-10-28 12:09:03 - WOPRAI, Steve Chesney
  Print publication without navigation


Steve Chesney of Redburn Atlantic, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $545 on, Jun 27th, 2024.

Steve has made no other calls on VRTX in the last 4 months.



There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 2 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $421 on, Tuesday, June 11th, 2024
  • Joseph Stringer of "Needham" Reiterated at Hold on, Tuesday, May 7th, 2024


These are the ratings of the 10 analyists that currently disagree with Steve


  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $555 on, Monday, June 24th, 2024
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $550 on, Monday, June 17th, 2024
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $500 on, Friday, May 31st, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $456 on, Tuesday, May 7th, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $462 on, Tuesday, May 7th, 2024
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $450 on, Thursday, April 18th, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
  • Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
Contributing Sources